Surveillance after curative resection of colorectal cancer.
about
Blood CEA levels for detecting recurrent colorectal cancerBlood CEA levels for detecting recurrent colorectal cancerPredictors of recurrence free survival for patients with stage II and III colon cancerMetachronous colorectal cancer in Taiwan: analyzing 20 years of data from Taiwan Cancer Registry.Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateRandomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.Strategies to evaluate synchronous carcinomas of the colon and rectum in patients that present for emergent surgeryPhysician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer.Surveillance instructions and knowledge among African American colorectal cancer survivors.Differential role of intravenous anesthetics in colorectal cancer progression: implications for clinical application.National and international guidelines for rectal cancer.Rectal Cancer Surveillance-Recurrence Patterns and Survival Outcomes from a Cohort Followed up Beyond 10 Years.Projections of cancer prevalence by phase of care: a potential tool for planning future health service needs.Induction of Apoptosis and Cell Cycle Arrest by Flavokawain C on HT-29 Human Colon Adenocarcinoma via Enhancement of Reactive Oxygen Species Generation, Upregulation of p21, p27, and GADD153, and Inactivation of Inhibitor of Apoptosis Proteins.The role of social support in posttreatment surveillance among African American survivors of colorectal cancer.A case of recurrent Cronkhite-Canada syndrome containing colon cancerPrognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients.Early detection of recurrence after curative resection for colorectal cancer - obstacles when using soluble biomarkers?Post-operative surveillance in retroperitoneal soft tissue sarcoma: The importance of tumor histology in guiding strategy.Elevated CEA is associated with worse survival in recurrent rectal cancer.The Roles of Adjuvant Supplements in Colorectal Cancer Patients on Chemotherapy - Reaping Benefits from Metabolic Crosstalk.Local recurrence of rectal cancer: a population-based cohort study of diagnosis, treatment and outcome.microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.Tumor location is an independent predictive factor for distant metastasis and metastatic sites of rectal adenocarcinoma in patients receiving total mesorectal excision.Evaluation of the Relationship between Carcinoembryonic Antigen and TNM Stage in Colorectal Cancer.
P2860
Q24186921-C21C25FE-5BE6-4343-9B64-95010755C369Q24194206-4CF56CDD-1AA2-4457-B26A-48BFA9BE68F6Q33645891-A585765E-4A94-4A9D-B223-A7A97E7FB238Q34152205-3CCA88C0-2744-45DB-956B-284D082B834FQ34166374-3DCBFC54-5F9D-4B08-BA45-9A9F4A106ED4Q34441837-C1CF5136-B01E-4CEC-9D7E-D9EDCD3049E6Q35035082-FE09FDB1-065B-4C35-AED9-4F119C4556EAQ35780153-F6C8C20E-3369-4C51-A84A-A5C53FB7F38EQ36152640-3B3C5D4B-F70B-425F-A161-68BEF54F4166Q36634545-66ADBF01-C5DF-4954-B994-BDAB8562BCB6Q37341238-3C12939E-9D3F-4F18-9F7F-71EF423A4E0BQ37628667-151F4FA0-B1DA-4FCF-9C7B-7EDC3449878BQ37718341-C92B990C-05A4-40B2-AE86-17B589775864Q38216889-6A5EB53B-A46E-4D6A-AF1E-5075F375ACD2Q38703197-911EFE4C-0929-4C43-AD06-336DB97BC73FQ39371265-FF9EC272-AF05-48A6-AAFF-D572F6855598Q41197378-336F34BB-2FBF-466F-A5BD-62362AA015F6Q41499986-9B06BA29-E51E-4D46-BBEA-EE7EE93151C8Q41872721-1A6C0440-A76A-4C08-A758-577FC5467633Q44176691-07A5B0F7-420C-40C8-8E9B-D5CCECF1233BQ44844409-C25BB87F-BDB7-402D-A7DB-3A75F07F9663Q46335861-D7261CC1-3480-4FD7-B388-C25113735F42Q47159963-5E65CBE4-9E96-44F0-91C6-55BCD5FFB537Q50089524-233EA409-E8EE-4545-A55F-0EFA8A89B07DQ51173380-3AE31454-DB80-41AC-A05E-47CC99373F24Q52595051-6946B137-0397-4665-B829-CF9E3507F1CDQ55019425-E37DC9C4-4328-4113-9768-5DEF53D10D89Q55555367-0ABB26AE-16EB-43C5-9B20-7426E29DEFFB
P2860
Surveillance after curative resection of colorectal cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Surveillance after curative resection of colorectal cancer.
@en
Surveillance after curative resection of colorectal cancer.
@nl
type
label
Surveillance after curative resection of colorectal cancer.
@en
Surveillance after curative resection of colorectal cancer.
@nl
prefLabel
Surveillance after curative resection of colorectal cancer.
@en
Surveillance after curative resection of colorectal cancer.
@nl
P2860
P356
P1476
Surveillance after curative resection of colorectal cancer
@en
P2093
Adena Scheer
P2860
P304
P356
10.1055/S-0029-1242464
P577
2009-11-01T00:00:00Z